NasdaqGS - Nasdaq Real Time Price • USD
Orthofix Medical Inc. (OFIX)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:03 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | -0.32 | -0.13 | -0.45 | 0.24 |
Low Estimate | -0.33 | -0.19 | -0.68 | -0.5 |
High Estimate | -0.32 | -0.07 | -0.23 | 0.99 |
Year Ago EPS | -0.1 | 0.02 | 0.01 | -0.45 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 4 | 4 |
Avg. Estimate | 184.28M | 196.4M | 791.02M | 846.8M |
Low Estimate | 183.2M | 195.5M | 788.9M | 838.4M |
High Estimate | 187.13M | 197.7M | 794.9M | 854.9M |
Year Ago Sales | 168.46M | 187.02M | 746.64M | 791.02M |
Sales Growth (year/est) | 9.40% | 5.00% | 5.90% | 7.10% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.51 | -0.47 | -0.21 | -0.08 |
EPS Actual | -0.1 | 0.02 | 0.07 | 0.02 |
Difference | 0.41 | 0.49 | 0.28 | 0.1 |
Surprise % | 80.40% | 104.30% | 133.30% | 125.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.32 | -0.13 | -0.45 | 0.24 |
7 Days Ago | -0.28 | -0.13 | -0.44 | 0.24 |
30 Days Ago | -0.28 | -0.13 | -0.44 | 0.24 |
60 Days Ago | -0.1 | -0.08 | -0.11 | 0.67 |
90 Days Ago | -0.1 | -0.08 | -0.11 | 0.67 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | 1 | -- | 1 | -- |
Growth Estimates
CURRENCY IN USD | OFIX | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -220.00% | -- | -- | 1.60% |
Next Qtr. | -750.00% | -- | -- | 10.50% |
Current Year | -4,600.00% | -- | -- | 5.20% |
Next Year | 153.30% | -- | -- | 13.30% |
Next 5 Years (per annum) | 9.40% | -- | -- | 11.22% |
Past 5 Years (per annum) | -38.07% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Maintains | Roth MKM: Neutral to Neutral | 3/7/2024 |
Initiated | Roth MKM: Neutral | 10/20/2023 |
Downgrade | BTIG: Buy to Neutral | 9/12/2023 |
Downgrade | Stifel: Buy to Hold | 9/12/2023 |
Upgrade | Stifel: Hold to Buy | 3/4/2022 |
Initiated | Stifel: Hold | 10/20/2020 |
Related Tickers
CNMD CONMED Corporation
72.64
+2.19%
ATEC Alphatec Holdings, Inc.
12.54
+1.62%
ZIMV ZimVie Inc.
15.43
-1.59%
FNA Paragon 28, Inc.
9.80
+1.55%
LIVN LivaNova PLC
52.33
-0.82%
KIDS OrthoPediatrics Corp.
30.31
+2.89%
AXGN AxoGen, Inc.
6.50
-0.76%
NVRO Nevro Corp.
12.07
-2.03%
SIBN SI-BONE, Inc.
15.42
+0.78%
GMED Globus Medical, Inc.
50.35
-0.79%